| Literature DB >> 29929466 |
Qin Zhao1, Ke Shi1, Zhi-Gang Yang2, Kai-Yue Diao1, Hua-Yan Xu1, Xi Liu1, Ying-Kun Guo3.
Abstract
BACKGROUND: Coarctation of aorta (CoA) may progressively develop aortic dilation at other site of the aorta and can lead to fatal aortic diseases. We aimed to evaluate the occurrence of aortic dilation and related predictors in patients with CoA using dual-source computed tomography (DSCT).Entities:
Keywords: Aorta; Aortic dilation; Coarctation of the aorta; Degree of coarctation; Dual-source computed tomography
Mesh:
Year: 2018 PMID: 29929466 PMCID: PMC6013956 DOI: 10.1186/s12872-018-0863-8
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Fig. 1CT images of a 10-year-old man with coarctation of the aorta. a Axial image shows the significant stenosis of aortic isthmus (white arrow). b Sagittal multiplanar reformatted image shows the measurement of aortic diameters at different levels: 1, ascending aorta; 2, pre-coarctation aorta; 3, aortic arch; 4, site of coarctation; 5, descending aorta after the site of coarctation; 6, descending aorta at level of diaphragm. c Volume rendering image shows a short segment aortic narrowing (white arrow) below the left subclavian artery
Fig. 2CT images of vascular abnormalities in CoA patients. Sagittal multiplanar reformatted image (a) shows a 16-year-old woman with CoA associated with dilated ascending aorta (asterisk) before the narrowing (white arrow). Sagittal multiplanar reformatted image (b) shows a 19-year-old man with CoA associated with dilated descending aorta (asterisk) after the narrowing (white arrow). Volume rendering image (c) shows a 53-year-old CoA woman with the narrowing (white arrow) and collateral circulation including enlarged internal mammary artery (arrowhead). Aortic dilation was considered if the z-score > 2
Characteristics in patients with mild and severe CoA
| All ( | Mild ( | Severe ( | ||
|---|---|---|---|---|
| Age (y) | 18.15 ± 18.48 | 13.84 ± 18.71 | 22.30 ± 17.60 | 0.096 |
| Male gender, n (%) | 34 (64.2%) | 14 (53.8%) | 20 (74.1%) | 0.158 |
| BSA (m2) | 1.06 ± 1.56 | 0.85 ± 0.50 | 1.26 ± 0.55 | 0.007 |
| Hypertension, n (%) | 19 (35.8%) | 6 (23.1%) | 13 (48.1%) | 0.086 |
| Simple CoA, n (%) | 18 (34.0%) | 7 (26.9%) | 11 (40.7%) | 0.387 |
| Associated cardiovascular complications | ||||
| BAV, n (%) | 9 (17.0%) | 5 (19.2%) | 4 (14.8%) | 0.728 |
| PDA, n (%) | 16 (30.2%) | 11 (42.3%) | 5 (18.5%) | 0.077 |
| VSD, n (%) | 15 (28.3%) | 9 (34.6%) | 6 (22.2%) | 0.372 |
| ASD, n (%) | 3 (5.7%) | 1 (3.8%) | 2 (7.4%) | 1.000 |
| AR, n (%) | 7 (13.2%) | 2 (7.7%) | 5 (18.5%) | 0.42 |
| AS, n (%) | 5 (9.4%) | 3 (11.5%) | 2 (7.4%) | 0.669 |
| Collateral circulation, n(%) | 21 (39.6%) | 6 (23.1%) | 15 (55.5%) | 0.024 |
| Z score of aorta | ||||
| Ascending aorta | 2.26 ± 0.51 | 2.10 ± 0.57 | 2.41 ± 0.39 | 0.025 |
| Pre-coarctation | 1.85 ± 0.52 | 1.83 ± 0.45 | 1.87 ± 0.59 | 0.743 |
| Aortic arch | 1.47 ± 0.40 | 1.49 ± 0.45 | 1.45 ± 0.34 | 0.659 |
| Post-coarctation | 1.93 ± 0.52 | 1.68 ± 0.43 | 2.17 ± 0.48 | < 0.001 |
| Aortic dilation | ||||
| Ascending aorta | 37 (69.8%) | 14 (53.8%) | 23 (85.2%) | 0.018 |
| Pre-coarctation | 20 (37.7%) | 9 (34.6%) | 11 (40.7%) | 0.779 |
| Aortic arch | 4 (7.5%) | 3 (11.5%) | 1 (3.7%) | 0.351 |
| Post-coarctation | 20 (37.7%) | 4 (15.4%) | 16 (59.3%) | 0.002 |
Values are showed as mean ± SD or count (percent)
P value stands for the difference between mild group and severe group
Abbreviations: BSA body surface area, CoA coarctation of aorta, BAV bicuspid aortic valve, PDA patent ductus arteriosus, VSD ventricular septal defect, AR aortic regurgitation, AS aortic valve stenosis
Correlation between z score of aorta and degree of coarctation
| r | ||
|---|---|---|
| Ascending aorta | −0.356 | 0.009 |
| Pre-coarctation | −0.077 | 0.584 |
| Aortic arch | 0.064 | 0.647 |
| Post-coarctation | −0.414 | 0.002 |
Univariate and multivariate analyses for the presence of ascending aortic dilation
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | |||
| Age | – | 0.0875 | – | 0.809 |
| Gender (Female sex) | 1.11 (0.33–3.74) | 0.869 | – | – |
| Hypertension | 1.34 (0.38–4.67) | 0.647 | – | – |
| BAV | 0.84 (0.18–3.87) | 0.882 | – | – |
| PDA | 0.93 (0.26–3.32) | 0.912 | – | – |
| VSD | 0.36 (0.10–1.25) | 0.107 | – | – |
| AR | 2.90 (0.32–26.33) | 0.343 | – | – |
| AS | – | 0.990 | – | – |
| Collateral circulation | 4.11 (1.00–16.84) | 0.050 | 8.35 (0.85–82.11) | 0.069 |
| Severity of CoA(severe) | 4.93 (1.33–18.31) | 0.017 | 7.46 (1.19–46.76) | 0.032 |
Abbreviations: OR odds ratio, CI confidence interval, BAV bicuspid aortic valve, PDA patent ductus arteriosus, VSD ventricular septal defect, AR aortic regurgitation, AS aortic valve stenosis, CoA coarctation of aorta
Univariate and multivariate analyses for the presence of post-coarctation aortic dilation
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | |||
| Age | – | 0.705 | – | – |
| Gender (male sex) | 0.94 (0.30–3.01) | 0.920 | – | – |
| Hypertension | 1.33 (0.42–4.21) | 0.624 | – | – |
| BAV | 0.79 (0.18–3.61) | 0.765 | – | – |
| PDA | 0.67 (0.19–2.31) | 0.523 | – | – |
| VSD | 0.17 (0.03–0.86) | 0.032 | 0.12 (0.01–0.80) | 0.106 |
| AR | 0.73 (0.01–0.66) | 0.020 | 0.04 (0.01–0.70) | 0.080 |
| AS | 2.74 (0.42–18.01) | 0.295 | – | – |
| Collateral circulation | 2.00 (0.64–6.23) | 0.232 | – | – |
| Severity of CoA(severe) | 8.00 (2.15–29.74) | 0.002 | 8.42 (1.84–38.56) | 0.006 |
Abbreviations: OR odds ratio, CI confidence interval, BAV bicuspid aortic valve, PDA patent ductus arteriosus, VSD ventricular septal defect, AR aortic regurgitation, AS aortic valve stenosis, CoA coarctation of aorta
Radiation dose estimation according to different age groups
| < 4 months | 4 months-1 year | 1-6 years | 6–14 years | > 14 years | |
|---|---|---|---|---|---|
| CDTIvol (mGy) | 6.86 ± 4.69 | 7.40 ± 6.06 | 11.82 ± 7.12 | 14.32 ± 7.87 | 28.91 ± 17.56 |
| DLP (mGy·cm) | 44.67 ± 33.38 | 47.09 ± 37.47 | 127.75 ± 73.25 | 179.71 ± 179.79 | 869.87 ± 741.10 |
| ED (mSv) | 1.74 ± 1.30 | 1.18 ± 1.00 | 2.30 ± 1.32 | 2.11 ± 2.18 | 6.31 ± 7.84 |
Abbreviations: CTDIvol volume CT dose index, DLP dose-length product, ED effective dose